Xonotlite Nanowire-Containing Bioactive Scaffolds for the Therapy of Defective Adipose Tissue in Breast Cancer

Nano Lett. 2023 Aug 9;23(15):7157-7165. doi: 10.1021/acs.nanolett.3c02016. Epub 2023 Jul 27.

Abstract

Considering the challenge in the treatment of severe breast tumor patients, xonotlite nanowire-containing bioactive scaffolds (Fe3O4-CS-GelMA) were fabricated by the 3D-printing technique for the therapy of injured adipose tissue after surgery. Importantly, benefiting from the excellent magnetothermal performance of Fe3O4 microspheres, Fe3O4-CS-GelMA scaffolds could effectively kill tumor cells in vitro and suppress breast cancer in vivo under an alternating magnetic field, and the tumor did not recur in 2 weeks. In addition, attributed to the released bioactive inorganic ions, Fe3O4-CS-GelMA composite scaffolds could effectively promote the expression of adipogenesis-related genes and proteins of adipose-derived stem cells (ADSCs) via the PI3K-AKT signaling pathway in vitro. Furthermore, Fe3O4-CS-GelMA scaffolds with ADSCs could obviously stimulate the formation of adipose in vivo, compared with that of pure GelMA without inorganic components. Therefore, this study offers a promising strategy for the therapy of breast tumors after the surgical excision of breast carcinoma.

Keywords: adipose tissue regeneration; breast cancer; magnetothermal therapy; xonotlite nanowire-containing bioactive scaffolds.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adipose Tissue
  • Breast Neoplasms* / drug therapy
  • Cell Differentiation
  • Female
  • Humans
  • Nanowires* / therapeutic use
  • Osteogenesis
  • Phosphatidylinositol 3-Kinases
  • Printing, Three-Dimensional
  • Tissue Engineering / methods
  • Tissue Scaffolds

Substances

  • calcium silicate
  • Phosphatidylinositol 3-Kinases